Global Biobanking Market, 2021-2027

February 2022 | 74 pages | ID: G6F1861A7685EN
Gen Consulting Company

Abstracts

Biobanking refers to the process by which samples of bodily fluid or tissue are collected for research use to improve our understanding of health and diseases. Garnering a CAGR of 4.6% from 2021 to 2027, the global biobanking market is projected to reach worth of USD 70,177 million by 2027-end, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biobanking market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The biobanking market is segmented on the basis of sample type, ownership, application, and region. The biobanking market is segmented as below:

By sample type:

• biofluids
• human tissues
• stem cells
• DNA/RNA
• others

By ownership:

• national & regional agencies
• universities
• non-profit organization
• private organization

By application:

• research
• therapeutics

By region:

• region
• Asia Pacific
• Europe
• North America
• Rest of the World (RoW)

The report also provides a detailed analysis of several leading biobanking market vendors that include All of Us, Biobank Graz, Biobank VAST, Danish National Biobank, Kaiser Permanente Research Bank, National Liver Disease Biobank, The Cancer Human Biobank (caHUB), UK Biobank Limited, Uppsala Biobank, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global biobanking market.
• To classify and forecast the global biobanking market based on sample type, ownership, application, and region.
• To identify drivers and challenges for the global biobanking market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biobanking market.
• To identify and analyze the profile of leading players operating in the global biobanking market.

Why Choose This Report

• Gain a reliable outlook of the global biobanking market forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

4.1 Introduction
4.2 Market dynamics
  4.2.1 Drivers
  4.2.2 Restraints

PART 5. GLOBAL MARKET FOR BIOBANKING BY SAMPLE TYPE

5.1 Biofluids
  5.1.1 Market size and forecast
5.2 Human tissues
  5.2.1 Market size and forecast
5.3 Stem cells
  5.3.1 Market size and forecast
5.4 DNA/RNA
  5.4.1 Market size and forecast
5.5 Others
  5.5.1 Market size and forecast

PART 6. GLOBAL MARKET FOR BIOBANKING BY OWNERSHIP

6.1 National & regional agencies
  6.1.1 Market size and forecast
6.2 Universities
  6.2.1 Market size and forecast
6.3 Non-profit organization
  6.3.1 Market size and forecast
6.4 Private organization
  6.4.1 Market size and forecast

PART 7. GLOBAL MARKET FOR BIOBANKING BY APPLICATION

7.1 Research
  7.1.1 Market size and forecast
7.2 Therapeutics
  7.2.1 Market size and forecast

PART 8. GLOBAL MARKET FOR BIOBANKING BY REGION

8.1 Asia Pacific
  8.1.1 Market size and forecast
8.2 Europe
  8.2.1 Market size and forecast
8.3 North America
  8.3.1 Market size and forecast
8.4 Rest of the World (RoW)
  8.4.1 Market size and forecast

PART 9. KEY COMPETITOR PROFILES

9.1 All of Us
9.2 Biobank Graz
9.3 Biobank VAST
9.4 Danish National Biobank
9.5 Kaiser Permanente Research Bank
9.6 National Liver Disease Biobank
9.7 The Cancer Human Biobank (caHUB)
9.8 UK Biobank Limited
9.9 Uppsala Biobank
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY